Staburo @ APF meeting On November 26, Staburo participated in the annual workshop of the APF (working group Pharmaceutical Research) by the International Biometric Society German Region. This year’s workshop (just like the one last year) took place virtually due to...

Staburo presents at lecture series ‚Mathematik im Beruf‘ at University of Konstanz  Susanne Steinhauser from Staburo GmbH presented the working life of a biostatistician at the ‘Mathematik im Beruf’ series at the University of Konstanz. The series of lectures aim to...

Staburo @ R/Pharma 2021 Conference Staburo participated in the R/Pharma 2021 Conference hosted by a committee existing of R practitioners from different companies, universities, and the FDA from the 2– 4 November. The conference took place online due to Covid19. The...

Christmas Party 2021 @ Staburo The Staburo Christmas Party followed the "tradition" of an online event for the second year in a row, but we made the best of the situation and had a very jolly time. As last year, the delivered food boxes contained a three-course menu,...

Staburo Sports Day “The man who moves a mountain begins by carrying away small stones.” – Confucius Overcoming the challenges of a pandemic can feel like trying to move a mountain, but on September 23rd we came together (with distance) as a group to move some stones....

Disclosure: FDA continues to take action on failure to submit required clinical trial information Last month, the FDA sent out a 3rd notice of noncompliance for not submitted clinical trial results, for the first time to the primary investigator of an academic...

Staburo's Isar picnic Finally, some socialising again! Since we all still work mainly from home, we were really looking forward to having a picnic together on the Isar – in the fresh air and with a lot of distance. Unfortunately, the weather didn't quite play along,...

JCO published results of Staburo-supported study investigating stem cell transplantation as a reasonable treatment option for older MDS patients The results of the so-called VidazaAllo Study - with Universitätsklinikum Hamburg-Eppendorf (UKE) being the sponsor - has...